General form of registration statement for all companies including face-amount certificate companies

Summary of Significant Accounting Policies (Details) - Schedule of anti dilutive common shares

v3.23.2
Summary of Significant Accounting Policies (Details) - Schedule of anti dilutive common shares - USD ($)
 3 Months Ended 12 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Dec. 31, 2022
Dec. 31, 2021
Schedule of Anti Dilutive Common Shares [Abstract]        
Net (loss) income (in Dollars) $ (4,762,078) $ 1,563,713 $ 38,726,259  
Weighted average shares outstanding (denominator for basic earnings per share) 3,747,145 1,702,997 1,900,397 1,567,772
Assumed exercise of stock options, treasury stock method (in Dollars)   $ 442    
Dilutive potential common shares   442    
Weighted average shares and assumed potential common shares (denominator for diluted earnings per share, treasury method) 3,747,145 1,703,439    
Basic earnings per share (in Dollars per share) $ (1.27) $ 0.92 $ (20.38) $ (12.96)
Diluted earnings per share (in Dollars per share) $ (1.27) $ 0.92    
Options 152,045 134,550 162,956 137,050
Warrants 3,435,728 557,696 3,435,728 557,695
Total potentially dilutive shares 3,587,773 692,246 3,598,684 694,745